US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+272 characters)
US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer
Article
Patent abstract
Methods, kits, and compositions are provided herein that can be used to treat CD20+ cancer using an anti-CD47 agent such as an antibody. The anti-CD47 agent can be used alone or in combination with one or more additional agent such as an anti-CD20 antibody.
Infobox
Is a
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chris Hidemi Mizufune Takimoto0
Jens-Peter Volkmer0
Mark Ping Chao0
Date of Patent
February 6, 2024
0Patent Application Number
162723500
Date Filed
February 11, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
